Abstract
Phosducin has recently been identified as a cytosolic protein that
interacts with the beta gamma-subunits of G proteins and thereby
may regulate transmembrane signaling. It is expressed predominantly
in the retina but also in many other tissues, which raises the question
of its potential specificity for retinal versus nonretinal beta gamma-subunits.
We have therefore expressed and purified different combinations of
beta- and gamma-subunits from Sf9 cells and have also purified transducin-beta
gamma from bovine retina and a mixture of beta gamma complexes from
bovine brain. Their interactions with phosducin were determined in
a variety of assays for beta gamma function: support of ADP-ribosylation
of alpha 0 by pertussis toxin, enhancement of the GTPase activity
of alpha 0, and enhancement of rhodopsin phosphorylation by the beta-adrenergic
receptor kinase 1 (betaARK1). There were only moderate differences
in the effects of the various beta gamma complexes alone on alpha
0, but there were marked differences in their ability to support
betaARK1 catalyzed rhodopsin phosphorylation. Phosducin inhibited
all beta gamma-mediated effects and showed little specificity toward
specific defined beta gamma complexes with the exception of transducin-beta
gamma (beta1 gamma1), which was inhibited more efficiently than the
other beta gamma combinations. In a direct binding assay, there was
no apparent selectivity of phosducin for any beta gamma combination
tested. Thus, in contrast to betaARK1, phosducin does not appear
to discriminate strongly between different G protein beta- and gamma-subunits.
Users
Please
log in to take part in the discussion (add own reviews or comments).